# ESOPEC (NCT02509286)

> Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02509286
- Phase: PHASE3
- Status: UNKNOWN
- Sponsor: University Hospital Schleswig-Holstein
- Conditions: Esophageal Adenocarcinoma (UICC TNM7); Adenocarcinoma of the Esophagogastric Junction
- Interventions: 5-Fluorouracil; Leucovorin; Oxaliplatin; Docetaxel; Carboplatin; Paclitaxel; Neoadjuvant radiation
- Enrollment: 438
- Primary outcome: Overall survival

## Commentary we found

- X threads: 243
- YouTube: 69
- Podcasts: 58
- X videos: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=esopec-nct02509286

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02509286", "email": "<work email>"}; the inbox owner confirms by the emailed link.